Member Info for extrader

Hi BillB,

.."At 3 times earnings.."
£ 46m of revenue, maybe 1/2 that in 'earnings' = profit, no ?

AIUI

.."Even mentions his Mello presentation in the RNS. .."

David Stredder owes him one ;-> !

Guinea (where the Ebola is....and where Simandou, China's biggest mine is ) is 3,000 Km from Zanaga/Congo . Straight line. Even further by land.

Guinea is 3000 Km as the crow flies from Congo-B.
Simandou - China's biggest mine in Africa - is in Guinea.....

HTH

Look at a map....
HTH

More like 'Shakespeare in Love', esp. the contributions by Sir Tom Stoppard (he of 'Rosenkrantsz and Guildenstern are dead') .
Signature line (appears 4 or 5 times) :

'It's a mystery'.

Nothing more detailed re 'iron ore' or similar than in prev years.

Lots of ESG type stuff, last sentence (Ivan) repeats 'responsible' , 'transition' and ' net zero by 2050' commitment.

Only specific ref to C-B is the rescheduling of the loan-for oil- facility (p 70)...and that SNPC would like a further rescheduling...quelle surprise (not).

.."Société Nationale des Pétroles du Congo (SNPC)
Glencore has provided a net $156 million (2019: $156 million) to SNPC repayable through future oil deliveries over five years.
As at 31 December 2020, the advance is net of $498 million (2019: $498 million) provided by the lenders, the repayment terms of which are contingent upon and connected to the future receipt of oil contractually due from SNPC.
Of the net amount advanced, $156 million (2019: $18 million) is due after 12 months and is presented within Other long-term receivables and loans and $Nil (2019: $138 million) is due within 12 months and included within Accounts receivable.

SNPC has indicated to Glencore and the syndicate of banks that it wishes to restructure the terms of this arrangement."

So, maybe a small 'sweetener' in any wrap-up deal, but hardly deal-clincher.

HTH

If they offered GLEN shares, it would be 'nice' to have some instrument safe-guarding ZIOC's 'tag along' rights for , say, a year or two, to make sure we didn't lose out on a quick 'flip'.

But we're getting more than a bit ahead of ourselves, I suspect !

Or, perhaps lower key than ref to FCA, give an update on when they expect to release the recent Q & A.

Hi Kr1ck,

Fair point !

I think some people (well, me, at least !) are mildly encouraged by this comment from the 3 Feb Production Report RNS :

.."As noted at our recent 2020 Investor Update, we continue to progress portfolio optimisation, and, in this regard, recently agreed terms for the sale of Mopani to an existing minority shareholder. Work continues to advance options around other non-core assets within the Group."

Putting together 'portfolio optimisation' with a 'sale' as a for instance of how one might 'optimise' and then concluding with 'options re other non-core assets' suggests - to me at least - that Zanaga has moved from the 'bottom drawer' cabinet and been dusted off.

Couple that with the Ivan/Gary handover and I could see Zanaga fitting in nicely into either a legacy trade or a 'new broom/new approach' trade.

Ivan and Gary - who both made their names/careers as coaltraders- have both AIUI said , when talking of the recent 'voluntary' coal sale cutbacks, that there are no sacred cows and they'd be willing to see the coal division itself sold off.

I see my 'confirmation bias' is kicking in, so better stop now !

HTH

Hi STOK,

OK, maybe I was waxing a bit lyrical re GLEN's potential 'pivot' ;->

At the very least, Zanaga's selling document (if such exists) can now add a cheeky 'environmentally [ relatively] friendly' claim that - from an 'optics/appearances' point of view - might just nudge someone to move a stage forward in the evaluation process.

I'm glad to see from your earlier post that you're positive !
Can you say any more about what particularly in your recent exchanges you found 'encouraging' ?

TIA and ATB

Thanks for this !

See also that there's been a flurry of press about 'green steel', see
https://timesnewsexpress.com/news/business/green-steel-the-race-to-clean-up-one-of-the-worlds-dirtiest-industries/ and today's FT article (behind paywall).

A lot of the suggestions - eg use of hydrogen instead of coal - are semi pie-in-the- sky long term 'solutions'.

A quick 'fix' in the transition would be to restrict feedstock to highest quality ore (as China has started doing), which plays to another of Zanaga's strengths.

As the ESG movement gathers steam (geddit ?) and it pragmatically cuts back 'voluntarily' on its coal business, maybe GLEN will pivot further and re-invent itself as a promoter of 'green ore' ;->

Chuzpah, I think it's called....

ATB

Cont....

The plan is to analyse in depth 250 x dengue patients through disease progression using hospital wearables (higher quality info because patients aren't moving around and there aren't 'signal quality/reception' issues that there are 'in the field'), then train up the 'learning algorithms' to make sense of all the data.

At the 'consumer' end, the idea would be to provide/distribute (according to budget) a range of wearables, the cheapest for passive monitoring/treatment of specific diseases ('come into hospital now')ranging up to wider scope/more predictive models for mass health monitoring purposes.

[In the UK, I think there's been some of this already , using oxygen levels as the 'prompt.

I imagine that the more predictive models - but for personal use - would be the area of interest to ORPH as data provider to fitbit/Apple, etc.

Presumably, the offering could be calibrated/priced according to 'coverage' : if I'm never going to the tropics, I don't need to monitor for tropical disease. Or I could upgrade temporarily : A bit like my mobile phone 'bolt on', maybe ?]

They'll be using some signal processing /machine learning techniques already developed by OUCRU for tetanus.

Damien touched on the difficulties of

- measuring effectiveness and 'economic value' (which might influence a Health Ministry willingness to support investment); and

- the ethical issues surrounding ownership of data.

One particular 'hot rail' topic is that apparently 'pulse oximetry' is less accurate in the BAME population, leading to unconscious 'racial bias' in the calibration of instruments,

See hxxps://www.nejm.org/doi/pdf/10.1056/NEJMc2029240?listPDF=true

The OUCRU/Imperial/Wellcome adopts a holistic approach, Damien's team include clinicians, engineers, data scientists and social scientists to progress from physiology > signals > clinicians > user.

The seminar gave me a bit of a better understanding of the practicalities and potential read-across for ORPH, I hope some of the above [ my interpretation] is of interest.

E&OE

ATB

Hi Trader_3,

Tying in with your post / links, I listened in to last Thursday's wearables seminar from IMSE Imperial, led by Damien Ming.

He specialises in tropical medicine and infectious diseases and his particular interest is 'the interface between data use and clinical healthcare, particularly in the use of machine learning analyses of pulse waveform signals."

The seminar is part of the OUCRU programme that you referenced hxxp://vital.oucru.org/mission-and-aim/.

The key goal is to come up with cost-effective technology [ie not 'high-resource'] solutions to (a) improve diagnosis and management of acute fevers in the community ; and (b) improve subsequent delivery of critical care to the worst affected.

Damien's starting point was that a lot of clinical observation hasn't changed much over the last 2,000 years...

- blood pressure; pulse; breathing patterns;alertness;
- vital sign monitoring provides trend data;
- clinical signs of deterioration show up before an 'event'.

In the West, a lot of wearables use (fitbit/Apple) has been driven by 'FirstWorld' motivators - 54% rewards; 45% games; 45% info; 44% savings; 36% 'looks good'.

The extra 'clinical' applications it currently uses are mostly things like :

- physical movement; and
- more granular analysis of the basics (blood pressure, pulse, cardio).

'Basic' can still yield 'actionable' info : Damien said that the US Centre for Disease Control had been able to identify a likely upcoming surge in Covid-19 cases from the rise in resting heart=rates of 200,000 monitored fitbit users.....

And there are now more high-tech things coming along like

- ECG activity via conductivity/impedance testing;
- O2 levels via oximetry;
- bio-sensing through sweat/tears / interstitial fluid readings;
- plasma/red cells levels (if I understood correctly).

This is all great 'data' but needs masses of analysis to provide context.

The Lower/Middle Income Countries (LMICs)are both 'relatively ' hi-tech (in terms of WiFi/ mobile phones etc) and low-resource (in terms of wide-spread availability/affordability of high-end hospital equipment).

So the idea is to make an up-front investment in gathering masses of focussed data (via CHIMs and/or intense/continuous monitoring)and process this in ways that allow/enable stratification of risk , which in turn allows a more rational , needs-based allocation of treatment.

In VietNam, they're starting with dengue, which is widespread albeit seasonally; isn't often fatal (5% need ICU) but economically very damaging and currently 'labour-intensive' because of frequent hospital visits, both for monitoring and treatment purposes. Kids are a particular problem because of difficulties giving blood samples.

Cont.....

.."The partners and clients of RegTech Open Project were the point..."

And my suggestion to you, based on the info/links I provided, is that the household names that you and RTOP tag as 'partners' are the companies who manufacture kit/develop software products and RTOP's 'clients' are the companies that they (re)sell stuff to
.
In other words, a pretty tenuous arm's length commercial relationship, unlikely to be a significant business 'driver'.

That's what it looks like to me, anyway.

HTH

I think you'll find that TAG's RegTechOpen Project (RTOP) role is as a re-seller :

(1) RTOP appear in the Gartner survey as ' Vendors' of Orbit 4BC

(2) These people https://www.glgroup.it/about-us/ say that they own Orbit Italy :

.."Founded in 2000 and acquired in 2011 by GL Group S.p.A., Orbit Italy is a BC consulting firm IT service provider, and software development leader. Our team of highly skilled and certified experts has extensive experience in business continuity, disaster recovery, and risk assessment process management..."

and here https://www.glgroup.it/orbit-4bc/

that Orbit-4BC is one of THEIR product lines; and, scrolling down on that page
that the MIR3 Business Continuity Management Service (that RTOP shows on its website) is "distributed by Orbit Italy, the only Italian company who can offer pre and post-sale technical support.."

HTH

(1) There's an ethical difference between giving a vaccine (attenuated, may have side effects) and deliberately infecting someone; OTOH

(2) The risk to volunteers in CHIMs has been likened to 'akin to driving a car for a year' (the 'materiality' issue figured quite a lot in the last Imperial-led focus group discussion that I took part in a few days ago).

'It's complicated'.

HTH

Hi Stevek1972,

Dannyaus1 referred to Azimut Holding, I replied to his 'mistake' re Azimut Holding.

You refer to Azimut Group...which still falls short of his claim.

Oh - And you're forgetting/omitting that AZ's comments were made several months back , when available figs would have been even lower....

HTH

It seems that others are questioning the motivation of posters :

CitySucker
@city_sucker
·
Feb 8
Replying to
@ShareTalkNews

" This confirms that banks have assigned funds to sme’s. It’s a bit tenuous but I’m guessing that #SYME are hoping that such funds may be funnelled through their monetising platform... AZ just throwing the dogs a bone..."

HTH

Hi Gotham/gasman 10,

Someone posted something that wasn't true, I posted a factual refutation.
They then repeated the false comment.

Do you have a problem with the truth ?